Nov. 7 (Thu)

Scientific Symposium 1

Current status of precision medicine in oncology area
Date & Time Nov. 7 (Thu), 09:00-10:15 Venue Room A
Chair
  • Emmanuel S. ANTONARAKIS (The Johns Hopkins University School of Medicine, USA)
  • Min-Hee RYU (Asan Medical Center, Korea)
  • Speaker
    1. 1.Precision medicine in NSCLC: Current interpretation of biomarkers from NGS
      Myung-Ju AHN (Samsung Medical Center, Korea)
    2. 2.Precision medicine in advanced prostate cancer
      Emmanuel S. ANTONARAKIS (The Johns Hopkins University, USA)
    3. 3.Gastric cancer in the era of precision medicine
      Jeeyun LEE (Samsung Medical Center, Korea)

    Scientific Symposium 2

    IT biotech & digital health in oncology
    Date & Time Nov. 7 (Thu), 09:00-10:15 Venue Room B
    Chair
  • Hyun Choel JUNG (Severance Hospital, Korea)
  • Joon Beom SEO (Asan Medical Center, Korea)
  • Speaker
    1. 1.AI, big data and oncology
      Yoon Sup CHOI (DHP, Korea)
    2. 2.Artificial intelligence for lung cancer imaging
      Kyu-Hwan JUNG (Vuno, Korea)
    3. 3.AI technologies for diagnosis of rare genetic cancer
      Changwon KEUM (3 Billion, Korea)
    4. 4.Deep learning for cancer precision medicine
      Seong Eui HONG (Theragen, Korea)

    Scientific Symposium 3

    Emerging strategies in immunotherapy
    Date & Time Nov. 7 (Thu), 09:00-10:15 Venue Room C
    Chair
  • Aung NAING (MD Anderson Cancer Center, USA)
  • Dae Ho LEE (Asan Medical Center, Korea)
  • Speaker
    1. 1.Promises and challenges of immunotherapy
      Aung NAING (MD Anderson Cancer Center, USA)
    2. 2.Emerging immuno-oncology targets and combination therapies
      Cathy PIETANZA (MSD, USA)
    3. 3.CAR-T therapy for solid tumors
      Edmund K MOON (University of Pennsylvania, USA)

    Scientific Symposium 4

    State of the art on systemic therapy in HCC
    Date & Time Nov. 7 (Thu), 09:00-10:15 Venue Room D
    Chair
  • Winnie YEO (The Chinese University of Hong Kong, Hong Kong)
  • Baek-Yeol RYOO (Asan Medical Center, Korea)
  • Speaker
    1. 1.Targeted therapy and biomarkers in hepatocellular carcinoma
      Changhoon YOO (Asan Medical Center, Korea)
    2. 2.Immunotherapy and biomarkers in hepatocellualar carcinoma
      Hong Jae CHON (CHA Bundang Medical Center, Korea)
    3. 3.Future of clinical trials in hepatocellular carcinoma
      Stephen L. CHAN (The Chinese University of Hong Kong, Hong Kong)

    Plenary Lecture 1

    Date & Time Nov. 7 (Thu), 10:30-11:10 Venue Room A
    Chair Young-Hyuck IM (Samsung Medical Center, Korea)
    Speaker Targeting DNA repair in Breast Cancer
    Andrew TUTT (The Institute of Cancer Research, UK)

    Presidential Sympsoium

    Date & Time Nov. 7 (Thu), 11:10-11:50 Venue Room A
    Chair Joung Soon JANG (Chung-Ang University Hospital, Korea)
    Speaker The VHL tumor suppressor gene: Insights into oxygen sensing and cancer
    William G. Kaelin, Jr. (Dana-Farber Cancer Institute, USA)

    Luncheon Symposium 1

    Date & Time Nov. 7 (Thu), 11:50-12:30 Venue TBD
    Chair TBD
    Speaker TBD

    Special Symposium

    Research, write, publish
    Date & Time Nov. 7 (Thu), 12:50-13:50 Venue Room A
    Chair
  • Masahiro TSUBOI (National Cancer Center Hospital East, Japan)
  • Jae Hong SEO (Korea University Guro Hospital, Korea)
  • Speaker
    1. 1.How to accept my manuscript to the high impact journal?
      Alex A. ADJEI (Mayo Clinic, USA)
    2. 2.Doing great research and writing great papers in high impact journals
      Jeong Ho LEE (KAIST, Korea)

    Multidisciplinary Oncology Team Education Session 1 *KOR

    Immuno-oncologic therapy and pharmacologic management
    Date & Time Nov. 7 (Thu), 12:50-13:50 Venue Room C
    Chair
  • Ae-Ryoung PARK (The Catholic University of Korea Seoul St. Mary's Hospital, Korea)
  • Sun Young KIM (Asan Medical Center, Korea)
  • Speaker
    1. 1.Immune checkpoint inhibitors
      Jung Ae SEO (National Cancer Center, Korea)
    2. 2.Identification and management of toxicities with immuno-oncologic therapy
      Juhyang CHEON (Yeungnam University Hospital, Korea)
    3. 3.Oncology pharmacist’s role in immuno-oncologic therapy
      Soyeon HONG (Seoul National University Bundang Hospital, Korea)

    ASCO/KSMO Joint Symposium

    Progress in precision medicine through global collaboration
    I. Utilization of NGS to improve patient care
    Date & Time Nov. 7 (Thu), 14:10-15:40 Venue Room A
    Chair
  • Edward Sanghyun KIM (Levine Cancer Institute, USA)
  • Yung-Jue BANG (Seoul National University Hospital, Korea)
  • Speaker
    1. 1.Precision genomics-based patients’ care - ASCO’s TAPUR study
      Edward Sanghyun KIM (Levine Cancer Institute, USA)
    2. 2.Clinical applications of NGS in Korea
      Tae-You KIM (Seoul National University Hospital, Korea)
    3. 3.Global collaboration in genomic data sharing and use
      Subha MADHAVAN (Georgetown University, USA)
    II. Integrated platform for precision medicine
    Date & Time Nov. 7 (Thu), 16:00-17:30 Venue Room A
    Chair
  • Tae-You KIM (Seoul National University Hospital, Korea)
  • Speaker
    1. 1.Integrated precision medicine platform for data-sharing in USA
      TBD
    2. 2.How can we incorporate NGS data-sharing platform for precision medicine in Korea?
      Woong Yang PARK (Samsung Medical Center, Korea)
    3. 3.KSMO-KCSG Korean precision medicine networking group initiative
      Jee Hyun KIM (Seoul National University Bundang Hospital, Korea)

    Scientific Symposium 5

    Modulating microenvironment for cancer treatment
    Date & Time Nov. 7 (Thu), 14:10-15:40 Venue Room B
    Chair Jin-Hyuk CHOI (Ajou University Hospital, Korea)
    Speaker
    1. 1.STING signaling regulates immune-vascular crosstalk to enhance anti-tumor immunity
      Chan KIM (CHA Bundang Medical Center, Korea)
    2. 2.Immune surveillance and the role of the endogenous angiogenesis inhibitors thrombospondin-1 and endostatin in tumor immunity
      Sandra RYEOM (UPENN, USA)
    3. 3.Leverages advanced technologies to investigate microbiomes and their clinical impact
      Julia OH (The Jackson Laboratory, USA)

    KOSRO/KSMO Joint Symposium

    The promise of combining RT and Immunotherapy
    Date & Time Nov. 7 (Thu), 14:10-15:40 Venue Room C
    Chair
  • David RABEN (University of Colorado, USA)
  • In Ah KIM (Seoul National University Bundang Hospital, Korea)
  • Speaker
    1. 1.Radiotherapy and Immunotherapy - New strategy for better outcome
      David RABEN (University of Colorado, USA)
    2. 2.Radiotherapy and Immunotherapy - On ongoing clinical trial
      Jin Ho KIM (Seoul National University Hospital, Korea)
    3. 3.Toxicities of the combination of radiotherapy and immunotherapy
      Keun-Wook LEE (Seoul National University Bundang Hospital, Korea)

    Multidisciplinary Oncology Team Education Session 2 *KOR

    Oncology nursing care in immune-oncology and targeted agent
    Date & Time Nov. 7 (Thu), 14:10-15:40 Venue Room D
    Chair
  • Yeon Hee PARK (Samsung Medical Center, Korea)
  • Onam OK (Samsung Medical Center, Korea)
  • Speaker
    1. 1.Principles of clinical advances of molecular targeted agent
      Moon Ki CHOI (National Cancer Center, Korea)
    2. 2.Principles of clinical advances of I-O
      Eun Joo KANG (Korea University Guro Hospital, Korea)
    3. 3.Management of molecular targeted agent-related AEs
      Jae Ho JEONG (Asan Medical Center, Korea)
    4. 4.Management of immune-related AEs
      Yun-Gyoo LEE (Kangbuk Samsung Hospital, Korea)

    Scientific Symposium 6

    Date & Time Nov. 7 (Thu), 16:00-17:30 Venue Room B
    Chair
  • Patrick TAN (Duke-NUS Medical School, Singapore)
  • Yeul Hong KIM (Korea University Anam Hospital, Korea)
  • Speaker
    1. 1.Development of CDK4/6 inhibitor for solid tumor
      Richard FINN (UCLA, USA)
    2. 2.Genetic landscape of hepatitis B virus–associated diffuse large B-cell lymphoma: insights for novel targeted therapies
      Qiang PAN-HAMMARSTRÖM (Karolinska Institutet, Sweden)
    3. 3.Genomic Predictors of Disease Progression in Gastrointestinal Cancer
      Patrick TAN (Duke-NUS Medical School, Singapore)
    Translational Research - Biomarker studies to achieve desired clinical applications

    Scientific Symposium 7

    GY cancer multimodality treatment
    Date & Time Nov. 7 (Thu), 16:00-17:30 Venue Room C
    Chair
  • Yong Man KIM (Asan Medical Center, Korea)
  • Speaker
    1. 1.The role of PARPi in ovarian cancer
      Keun Ho LEE (The Catholic University of Korea Seoul St. Mary's Hospital's Hospital, Korea)
    2. 2.IO for ovarian cancer  
      Gun Min KIM (Yonsei Cancer Center, Korea)
    3. 3.Combination of PARP inhibitors and Immune checkpoint inhibitors in ovarian cancer 
      Jung-Min LEE (National Cancer Institute, USA)
    4. 4.International collaboration in GY cancer clinical research
      Elise C. KOHN (National Cancer Institute, USA)

    KCCA Symposium

    The Current State and System of Overseas Drug Accessibility
    Date & Time Nov. 7 (Thu), 16:00-17:30 Venue Room D
    Chair TBD
    Speaker
    1. TBD

    Nov. 8 (Fri)

    Scientific Symposium 8

    Partnering between biotechs and investigators in early phase drug development
    Date & Time Nov. 8 (Fri), 09:00-10:30 Venue Room A
    Chair
  • Tae Won KIM (Asan Medical Center, Korea)
  • Stefan GLÜCK (GMA Oncology & Early Assets, USA)
  • Speaker
    1. 1.How to navigate turbulent biotech as an investigator?
      James Jungkue LEE (Bridge Biotherapeutics, Inc., Korea)
    2. 2.PharmAbcine story and its Perspective in Oncology
      Jin-San YOO (PharmAbcine, Korea)
    3. 3.Microbiome meets Cancer and Immunology
      Hansoo PARK (Genome & Company, Korea)
    4. 4.Who are the preferred investigators for global early phase clinical trials?
      Hyunjung Helen LEE (Samyang Biopharm USA, Korea)

    Scientific Symposium 9

    Precision oncology and cancer epigenetics
    Date & Time Nov. 8 (Fri), 09:00-10:30 Venue Room B
    Chair Sung-Soo YOON (Seoul National University, Korea)
    Speaker
    1. 1.Understanding and targeting the epigenome in liver cancer
      Keith D. ROBERTSON (Mayo Clinic, USA)
    2. 2.Molecular mechanism underlying epigenetic carcinogenesis
      Young-Joon KIM (Yonsei University, Korea)
    3. 3.Epigenetic aberration of malignant lymphoma and its therapeutic application
      Young-Hyeh KO (Samsung Medical Center, Korea)

    KCSG/KSMO Joint Symposium

    Multidisciplinary efforts for awareness and minimizing toxicities from systemic cancer therapy
    Date & Time Nov. 8 (Fri), 09:00-10:30 Venue Room C
    Chair
  • Eric LANCASTER (UPENN, USA)
  • Jin-Hyoung KANG (Seoul St. Mary’s Hospital, Korea)
  • Speaker
    1. 1.Endocrinopathy
      Tae Jung OH (Seoul National University Bundang Hospital, Korea)
    2. 2.Cardiovascular problems (CHF, arrhythmia etc)
      TBD
    3. 3.Neurologic toxicities
      Eric LANCASTER (UPENN, USA)
    4. 4.Real-world data of immune checkpoint inhibitor toxicities in Korean NSCLC patients: Is there any ethnic difference?
      Jin-Hyoung KANG (The Catholic University of Korea Seoul St. Mary's Hospital, Korea)

    Plenary Lecture 2

    Date & Time Nov. 8 (Fri), 10:50-11:30 Venue Room A
    Chair Si-Young KIM (Kyung Hee University Hospital, Korea)
    Speaker Past, present and future of geriatric oncology
    Hans WILDIERS (University Hospitals Leuven, Belgium)

    Noe Kyeong Kim Memorial Award & Lecture

    Date & Time Nov. 8 (Fri), 11:30-12:10 Venue Room A
    Chair TBD
    Speaker TBD

    Luncheon Symposium 3

    Date & Time Nov. 8 (Fri), 12:10-12:50 Venue TBD
    Chair TBD
    Speaker TBD

    Plenary Lecture 3

    Date & Time Nov. 8 (Fri), 10:50-11:30 Venue Room A
    Chair Myung-Ju AHN (Samsung Medical Center, Korea)
    Speaker The reality versus potential of immune check-point inhibitors as cancer therapeutics
    Heather WAKELEE (Stanford University , USA)

    JSMO/KSMO Joint Symposium

    Clinical Trials in Asia: Opportunities and Challenges
    Date & Time Nov. 8 (Fri), 14:00-15:30 Venue Room A
    Chair TBD
    Speaker
    1. 1.How to make the biopharma companies to decide to conduct clinical trials in Asia?
      Takayuki YOSHINO (National Cancer Center Hospital East, Japan)
    2. 2.Early phase 1 clinical research capabilities in Japan
      Toshio SHIMIZU (National Cancer Center Hospital Japan, Japan)
    3. 3.Early clinical research capabilities in Korea
      Do-Youn OH (Seoul National University Hospital, Korea)
    4. 4.JSMO-KSMO collaboration for clinical trials
      Sun Young RHA (Yonsei Cancer Center, Korea)

    Scientific Symposium 10

    Geriatric Oncology
    Date & Time Nov. 8 (Fri), 14:00-15:30 Venue Room B
    Chair
  • Ravindran KANESVARAN (National Cancer Centre Singapore, Singapore)
  • Si-Young KIM (Kyung Hee University Hospital, Korea)
  • Speaker
    1. 1.Geriatrics for oncologists
      Kwang Il KIM (Seoul National University Hospital, Korea)
    2. 2.Predicting outcome of older patients with cancer – Sharing Korean experiences
      Jee Hyun KIM (Seoul National University Bundang Hospital, Korea)
    3. 3.How to improve cancer care for older patients - Sharing Singaporian experiences
      Ravindran KANESVARAN (National Cancer Centre Singapore, Singapore)
    4. 4.Breast cancer in older women
      Hans WILDIERS (University Hospitals Leuven, Belgium)

    KSSO/KSMO Joint Symposium

    Evolving strategies for surgery and systemic therapy in the neoadjuvant treatment era
    Date & Time Nov. 8 (Fri), 14:00-15:30 Venue Room C
    Chair
  • Paul F. MANSFIELD (MD Anderson Cancer Center, USA)
  • Jae Yong CHO (Gangnam Severance Hospital, Korea)
  • Speaker
    1. 1.Neoadjuvant treatment for gastric cancer in Western countries
      Paul F. MANSFIELD (MD Anderson Cancer Center, USA)
    2. 2.Neoadjuvant treatment for gastric cancer in East Asian countries
      Masanori TERASHIMA (Shizuoka Cancer Center, Japan)
    3. 3.Conversion surgery in metastatic gastric cancer
      Eun-Kee SONG (Chonbuk National University Hospital, Korea)

    KSP/KSMO Joint Symposium

    Immune Biomarker
    Date & Time Nov. 8 (Fri), 15:50-17:20 Venue Room A
    Chair TBD
    Speaker
    1. 1.MSI-H in pan-tumor
      Patricia MARINELLO (MSD, USA)
    2. 2.TMB: the role in IO prediction
      Ji-hun KIM (Asan Medical Center, Korea)
    3. 3.PD-L1 in routine practice
      Tae-Jung KIM (The Catholic University of Korea Yeouido St. Mary's Hospital, Korea)
    4. 4.Multiplex immunoprofiling in cancer
      Hee Jin LEE (Asan Medical Center, Korea)

    Scientific Symposium 11

    Radiomics: Primer for medical oncologists
    Date & Time Nov. 8 (Fri), 15:50-17:20 Venue Room B
    Chair
  • Seung Hong CHOI (Seoul National University Hospital, Korea)
  • Ho Yun LEE (Samsung Medical Center, Korea)
  • Speaker
    1. 1.Radiomics and Deep learning in Differential Diagnosis and Molecular Classification
      Ji Eun PARK (Asan Medical Center, Korea)
    2. 2.Radiomics and Deep Learning in Monitoring Treatment Response
      Philipp KICKINGEREDER (Heidelberg University Hospital, Germany)
    3. 3.Oncologist's view of radiomics
      Kyu Pyo KIM (Asan Medical Center, Korea)
    4. 4.Radiomics in thoracic oncology
      Ho Yun LEE (Samsung Medical Center, Korea)

    Oncology Multi-disciplinary Symposium

    Multi-disciplinary Discussion on the Reimbursement Criteria of Imaging Studies in Cancer Patients
    Date & Time Nov. 8 (Fri), 15:50-17:20 Venue Room C
    Chair TBD
    Speaker TBD

    Multidisciplinary Oncology Team Education Session 3 *KOR

    CRC/CRA in clinical trial of precision medicine
    Date & Time Nov. 8 (Fri), 15:50-17:20 Venue Room D
    Chair
  • Hwan Jung YUN (Chungnam National University Hospital, Korea)
  • Seok Yun KANG (Ajou University Hospital, Korea)
  • Speaker
    1. 1.Recent trend of clinical trials in a precision medicine era
      Jeong Eun KIM (Asan Medical Center, Korea)
    2. 2.Real experience of a basket trial: K-basket trial
      Min Hwan KIM (Yonsei Cancer Center, Korea)
    3. 3.Real experience of a umbrella trial: TRIUMPH trail in H&N cancer, biomarker-integrated umbrella, advanced gastric cancer
      Hee Kyung AHN (Gachon University Gil Medical Center, Korea)